Category: neuroendocrine tumors

App, Carcinoid NETs on desktop or mobile

New — Carcinoid NETs Mobile App — Keeping Track of Your Health Just Got Easier!

April 1, 2015

The Carcinoid Cancer Foundation is pleased to announce that a new unique tool for carcinoid/NETs patients and their caregivers is now available!

The Carcinoid NETs self-care tool, powered by Health Storylines™ allows you to track your mood, symptoms,…

READ MORE
Cy Ball, carcinoid, SoundCloud music

Cancer and Meditation by Cy Ball

March 19, 2015

Our guest blogger this month is Cy Ball, a retired computer software developer, enthusiastic fly fisherman, and music producer. He was diagnosed with carcinoid cancer about a year after his retirement, with a primary tumor in his intestinal area (still…

READ MORE
Theranostics 3rd World Congress

3rd Theranostics World Congress Offers Free Patient Program on March 14

February 27, 2015

Johns Hopkins University in Baltimore, Maryland will be the site of the 3rd Theranostics World Congress on Ga-68 & PRRT from March 12-14, 2015. Co-sponsored by the Society of Nuclear Medicine and Molecular Imaging and Johns Hopkins Medicine, the…

READ MORE
Learn More About NET Cancer, NET Cancer Day

Intelligent Patients — Just What the Doctor Didn’t Order by Ronny Allan

January 28, 2015

The Carcinoid Cancer Foundation is pleased to announce that we are going to feature guest contributors to our blog during 2015. Intelligent Patients – Just What the Doctor Didn’t Order by Ronny Allan (pictured), a carcinoid cancer patient from the UK,…

READ MORE
Immunotherapy Researchers, June, Hu, Kunz

10 Highlights of the Year 2014 for the Carcinoid and Neuroendocrine Tumor Community

December 18, 2014

As the Carcinoid Cancer Foundation looks back on the year 2014, we reached out to physicians, patients, support group leaders, listserv managers, patient advocates, and business colleagues to see what they thought were among the highlights of the past…

READ MORE
FDA logo

Breaking News: US FDA Approves Lanreotide for Gastroenteropancreatic Neuroendocrine Tumors

December 16, 2014

December 16, 2014: The US Food and Drug Administration (FDA) today approved “lanreotide (Somatuline Depot Injection, Ipsen Pharma) for the treatment of patients with unresectable, well or moderately differentiated, locally advanced or metastatic

READ MORE
Gallium-68 DOTA-TATE (chemical structure)

Carcinoid Cancer Foundation Awards Grant to Stanford University

June 30, 2014

The Carcinoid Cancer Foundation in White Plains, New York has awarded a grant of more than $65,000.00 to Stanford University in California to expand access to its Gallium-68 (Ga-68) DOTA-TATE PET/CT program for carcinoid and neuroendocrine tumor (NET)…

READ MORE
Suzi Garber_2

Zebra Talk — A Handbook for Newly Diagnosed Carcinoid & Neuroendocrine Tumor Patients and Their Primary Care Physicians

June 11, 2014

There’s a terrific new resource for carcinoid and neuroendocrine tumor patients and their primary care physicians entitled Zebra Talk. According to Suzi Garber of Bucks County, Pennsylvania, editor, the handbook “is intended as a reference for those…

READ MORE
Larry K. Kvols, MD

NET Alliance Issues New E-Book on Neuroendocrine Cancer

May 12, 2014

NETrospectives, a new e-book produced by The NET Alliance, is “a journey through the past and a vision for the future of neuroendocrine cancer.” The e-book presents patients, patient advocates, and physicians talking about the diagnoses…

READ MORE
Celia M. Divino, MD, New York Daily News article, April 27, 2014

Carcinoid and Neuroendocrine Tumors in the News!

May 3, 2014

Who is at risk for getting carcinoid or another neuroendocrine cancer? What are the signs and symptoms? We are very pleased to share a feature article from the April 27, 2014 edition of the New York Daily News, Daily Checkup: Carcinoid Tumors Have a Variety

READ MORE